Karen Yeomans

Executive Director, Data Analytics, Real-World Evidence

Karen contributes to Evidera’s real-world evidence strategic and operating plans and has played a key role in the integration of operational and scientific delivery to better serve our clients’ needs. She has over a decade of experience in the consulting industry with a focus on non-interventional study design involving primary data collection and retrospective methods. Methodologies have included real-world evidence data collection, spanning multinational retrospective chart reviews, patient and physician surveys, registries, and post-approval safety studies.

Karen has experience in the fields of chronic pain, constipation, allergy, oncology, migraine, smoking cessation, acne, rosacea, cystic fibrosis, heart failure, mental illness, and rare diseases. She has co-authored publications in peer-reviewed journals such as the Journal of Clinical Psychopharmacology, Journal of Managed Care & Specialty Pharmacy, Pain Medicine, ClinicoEconomics and Outcomes Research, British Journal of Haematology, Journal of Clinical and Aesthetic Dermatology, International Journal of Clinical Practice, and Cephalalgia, and has presented at conferences worldwide.

Prior to joining Evidera, Karen worked as a senior manager and senior research scientist at UBC: An Express Scripts Company. Prior to that, she worked for four years in PR&D at Merck Frosst.

Karen completed her BSc at McGill University with an emphasis in biochemistry and is fluent in English, French, and Spanish.